MESSA, MARIA CRISTINA
 Distribuzione geografica
Continente #
AS - Asia 930
NA - Nord America 743
EU - Europa 178
SA - Sud America 156
AF - Africa 13
OC - Oceania 2
AN - Antartide 1
Totale 2.023
Nazione #
US - Stati Uniti d'America 716
SG - Singapore 424
CN - Cina 174
BR - Brasile 129
HK - Hong Kong 105
VN - Vietnam 86
FR - Francia 61
IT - Italia 42
JP - Giappone 38
KR - Corea 26
BD - Bangladesh 21
IN - India 16
CA - Canada 15
GB - Regno Unito 14
NL - Olanda 10
AR - Argentina 9
DE - Germania 9
ID - Indonesia 7
MX - Messico 6
PL - Polonia 6
FI - Finlandia 5
CO - Colombia 4
ES - Italia 4
IQ - Iraq 4
PK - Pakistan 4
UA - Ucraina 4
VE - Venezuela 4
CZ - Repubblica Ceca 3
EC - Ecuador 3
IL - Israele 3
PE - Perù 3
PH - Filippine 3
RS - Serbia 3
RU - Federazione Russa 3
TR - Turchia 3
ZA - Sudafrica 3
AU - Australia 2
AZ - Azerbaigian 2
BH - Bahrain 2
CL - Cile 2
EG - Egitto 2
ET - Etiopia 2
MA - Marocco 2
PT - Portogallo 2
SV - El Salvador 2
UZ - Uzbekistan 2
AL - Albania 1
AM - Armenia 1
AQ - Antartide 1
AT - Austria 1
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
BW - Botswana 1
CH - Svizzera 1
DZ - Algeria 1
EE - Estonia 1
GR - Grecia 1
GT - Guatemala 1
IE - Irlanda 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MD - Moldavia 1
MT - Malta 1
MY - Malesia 1
NP - Nepal 1
OM - Oman 1
PY - Paraguay 1
QA - Qatar 1
RO - Romania 1
SA - Arabia Saudita 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 2.023
Città #
Santa Clara 406
Singapore 237
Hong Kong 105
San Jose 69
Hefei 61
Beijing 44
Lauterbourg 44
Ashburn 43
Tokyo 34
Ho Chi Minh City 29
Seoul 26
Hanoi 25
São Paulo 18
Los Angeles 13
New York 13
Dallas 10
Toronto 7
Da Nang 6
London 6
Orem 6
Chicago 5
Helsinki 5
Warsaw 5
Amsterdam 4
Curitiba 4
Haiphong 4
Indianapolis 4
Milan 4
Montreal 4
Nuremberg 4
Rio de Janeiro 4
Rome 4
Belgrade 3
Bogotá 3
Bologna 3
Campinas 3
Delhi 3
Jakarta 3
Minamishinagawa 3
Phoenix 3
Phủ Lý 3
Porto Alegre 3
Ribeirão Preto 3
Thái Nguyên 3
Acalanes Ridge 2
Addis Ababa 2
Americana 2
Ardea 2
Atlanta 2
Baku 2
Bengaluru 2
Boston 2
Bắc Ninh 2
Charlotte 2
Chennai 2
Ciampino 2
City of London 2
Council Bluffs 2
Denver 2
Elk Grove Village 2
Famões 2
Frankfurt am Main 2
Guangzhou 2
Hialeah 2
Hải Dương 2
Johannesburg 2
Lima 2
Madrid 2
Marseille 2
New Delhi 2
Newark 2
Nova Iguaçu 2
Paris 2
Piscataway 2
Salvador 2
San Salvador 2
Seattle 2
Tashkent 2
Thái Bình 2
Vũng Tàu 2
Abbeville 1
Albany 1
Alegrete 1
Alvorada 1
Amarillo 1
Amherst 1
Amman 1
Araçatuba 1
Areial 1
Arnold 1
Aryanah 1
Astana 1
Athens 1
Barletta 1
Barquisimeto 1
Basra 1
Bastrop 1
Bello 1
Berisso 1
Bethlehem 1
Totale 1.381
Nome #
11C-Choline PET/CT Predicts Prostate Cancer-Specific Survival in Patients with Biochemical Failure During Androgen-Deprivation Therapy. 88
Use of early dynamic 11C-choline PET/CT acquisition for the detection of local recurrence in prostate cancer patients with biochemical failure after radical prostatectomy 70
Evaluation of Erlotinib treatment response in non-small-cell lung cancer (NSCLC) using EORTC, PERCIST and RECIST 68
Role of (18)F-FDG PET in the management of gestational trophoblastic neoplasia 55
Prognostic Value of pre-therapy 18FDG PET/CT for the Outcome of 18FDG PET-guided SIB-IMRT in Patients with Head and Neck Cancer 53
Dosimetry in radio-guided sentinel lymph node dissection in patients with prostate carcinoma 51
Cancer cell growth and survival as a system-level property sustained by enhanced glycolysis and mitochondrial metabolic remodeling. 49
Genetic, clinical and radiographic signs in knee osteoarthritis susceptibility. 48
Correlation between 18FDG PET SUV with Partial Volume Correction and MRS Choline signal integral in breast cancer 47
Preoperative 18F-FDG PET/CT in patients with high-risk clinical early-stage endometrial cancer 46
Sarcoidosis mimicking metastatic gynaecological malignancies: A diagnostic and therapeutic challenge? 46
Metabolic and anatomic criteria use in evaluation of Erlotinib treatment response 45
Prognostic value of pre-therapy 18F-FDG PET/CT for the outcome of radiotherapy treatment in patients with head and neck cancer 44
Genotyping analysis and 18FDG uptake in breast cancer patients: a preliminary research 44
Predictive value of pre-therapy 18F-FDG PET/CT for the outcome of 18F-FDG PET-guided radiotherapy in patients with head and neck cancer 44
A new algorithm (MotionFreeze-MF) for respiratory motion management in PET/CT scan: Comparison to respiratory gated PET/CT (4D) data 43
18FDG PET/CT Image-Guided Simultaneous Integrated Boost Intensity-Modulated Radiotherapy in Head and Neck cancer 43
Prognostic value of quantitative 18F-FDG PET biomarkers in breast cancer 43
Maximum standardized uptake value (SUVmax) as prognostic factor for surgical cytoreduction and response to adjuvant chemotherapy in women submitted to 18F-FDG PET/CT for staging of advanced epithelial ovarian cancer (aEOC) 42
Dose distribution changes with shielding disc misalignments and wrong orientations in breast IOERT: a Monte Carlo - GEANT4 and experimental study 42
Added value of PET/CT in the evaluation of Burkitt Lymphoma in adults 42
SUV-volume Histogram as tool for MRgFUS bone metastasis treatment monitoring 41
(11)C]Choline Positron Emission Tomography/Computerized Tomography for Early Detection of Prostate Cancer Recurrence in Patients with Low Increasing Prostate Specific Antigen. 41
Added diagnostic value of respiratory gated (4D) PET/CT in detection of neoplastic liver lesions 40
Feasibility of perfusion CT technique integrated into conventional (18)FDG/PET-CT studies in lung cancer patients: clinical staging and functional information in a single study 40
Comparative evaluation of CT-based and respiratory-gated PET/CT-based planning target volume (PTV) in the definition of radiation treatment planning in lung cancer: preliminary results 39
Impact of time-of-flight (TOF) and point-spread-function (PSF) PET on whole-body oncologic studies 39
[11C]choline PET/CT for the detection of tumor recurrence in prostate cancer patients with PSA<1.5 ng/mL 39
Accuracy of [11C]CHOLINE PET/CT in patients with prostate cancer recurrence localized to a single lymph node at imaging: Results from a pathological-validated series 38
Metabolic impact of partial volume correction of [18F]FDG PET-CT oncological studies on the assessment of tumor response to treatment. 38
The clinical value of 18F-FDG PET/CT in the management of patients with suspected infection and fever of unknown origin 38
DVWA gene polymorphisms and osteoarthritis 38
Helical tomotherapy treatment planning of lymph-node relapses in prostate cancer: Clinical value of 11C-Choline PET/CT 36
18F-FDG PET/CT in staging of advanced epithelial ovarian cancer (aEOC): evaluation of the prognostic value of stage III to IV migration 36
Feasibility and Safety of Sentinel Lymph Node Biopsy in Localized Prostate Cancer 34
High Intensity Focused Ultrasound: opportunità e sfide della chirurgia ablativa non invasiva sotto guida a Risonanza Magnetica. 33
One-year-experience in the use of Partial Volume Correction impact on the role of 18FDG PET for the diagnosis, prognosis and therapy monitoring toward personalized medicine in oncology 32
The diagnostic, prognostic and treatment monitoring role of pretherapy 18F-FDG PET toward personalized medicine in oncology: one-year experience in the use of partial volume correction 31
Incidental Finding of Parathyroid Adenoma With 11C-Choline PET/CT 31
Lymph nodal metastases: diagnosis and treatment 30
Role of PET/CT in the clinical management of locally advanced pancreatic cancer 28
Contrast enhanced (ce) CT in staging and end-of-treatment evaluation in lymphoma in the FDG PET/CT era: A need or a habit? 28
Respiratory gated PET/CT in a European multicentre retrospective study: added diagnostic value in detection and characterization of lung lesions 27
PET/CT and contrast enhanced CT in single vs. two separate sessions: a cost analysis study 26
Clinical and diagnostic assessment for therapeutic decisions in prostate cancer 26
Role of FDG PET/CT in the preoperative staging of high-risk clinical early stage endometrial cancer 25
Unusual presentation of sarcoid-like reaction on bone marrow level associated with mediastinal lymphadenopathy on (18)F-FDG-PET/CT resembling an early recurrence of Hodgkin's Lymphoma. 24
Prognostic value of 18FDG PET-CT in patients with head and neck cancer candidates to radical radiotherapy 24
Metabolic signature of breast cancer patients negative and positive to 18F-FDG PET screening 23
Integration of Hybrid Single-Photon Emission Computed Tomography/Computed Tomography in the Preoperative Assessment of Sentinel Node in Patients With Cervical and Endometrial Cancer Our Experience and Literature Review 23
Role of FDG-PET in the management of gestational trophoblastic neoplasia (GTN) 22
Totale 2.023
Categoria #
all - tutte 5.782
article - articoli 5.710
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.492


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202411 0 0 0 0 0 0 0 0 4 0 5 2
2024/2025893 3 2 60 38 346 55 4 52 9 11 163 150
2025/20261.119 52 62 82 163 241 27 161 53 70 100 108 0
Totale 2.023